Athena Global Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$850K Sell
10,111
-2,461
-20% -$197K 2.55% 19
2016
Q4
$1.01M Hold
12,572
2.45% 19
2016
Q3
$1.01M Sell
12,572
-9,939
-44% -$796K 2.62% 17
2016
Q2
$1.77M Sell
22,511
-13,558
-38% -$1.02M 2.73% 16
2016
Q1
$2.6M Hold
36,069
2.67% 17
2015
Q4
$3.04M Hold
36,069
2.91% 14
2015
Q3
$3.02M Sell
36,069
-19,306
-35% -$1.63M 3.06% 14
2015
Q2
$4.62M Sell
55,375
-23,207
-30% -$1.77M 4.17% 11
2015
Q1
$5.71M Sell
78,582
-1,238
-2% -$88.1K 4.04% 10
2014
Q4
$5.51M Sell
79,820
-71,696
-47% -$4.84M 3.77% 11
2014
Q3
$9.83M Hold
151,516
4.48% 7
2014
Q2
$9.42M Buy
151,516
+33,182
+28% +$1.98M 4.19% 9
2014
Q1
$6.96M Buy
+118,334
New +$6.6M 4.2% 9

Other funds holding LLY

Athena Global Investors's LLY Position: Q1 2017 in Review

Athena Global Investors reduced its Eli Lilly (LLY) stake by 20% in Q1 2017, selling an estimated $197K and leaving 10,111 shares worth $850K. The position accounts for 2.55% of the portfolio, ranked #19.

Athena Global Investors first reported a position in LLY in Q1 2014 and has held it in 13 quarters since. The position peaked at $9.83M in Q3 2014. 1,250 funds tracked by Wall St. Rank hold LLY as of Q1 2017.

  • Athena Global Investors held 10,111 shares of Eli Lilly worth $850K as of Q1 2017.
  • Athena Global Investors sold 2,461 Eli Lilly shares in Q1 2017, an estimated $197K.
  • Eli Lilly made up 2.55% of Athena Global Investors's portfolio in Q1 2017, its #19 holding.
  • Athena Global Investors first reported a position in Eli Lilly in Q1 2014 and has held it in 13 quarters since.
  • Athena Global Investors's Eli Lilly position peaked at $9.83M in Q3 2014.
  • 1,250 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.

Based on Athena Global Investors's 13F filing for Q1 2017, filed 16 May 2017.